Omnicell (OMCL) Amortization of Deferred Charges (2016 - 2026)
Omnicell's (OMCL) quarterly Amortization of Deferred Charges came in at $304000.0 in Q2 2026, up 3.4% year-over-year from $294000.0 in Q2 2025, and down 38.83% quarter-over-quarter from $497000.0 in Q1 2026.
Analysis
Omnicell (OMCL) Amortization of Deferred Charges (2016 - 2026) Analysis & Trends
Omnicell (OMCL) has reported Amortization of Deferred Charges for 11 consecutive years, with $304000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Amortization of Deferred Charges rose 3.4% year-over-year to $304000.0 in Q2 2026; TTM through Jun 2026 was $1.6 million, a 40.41% decrease from a year earlier, with the FY2025 full-year figure at $2.7 million, down 30.02% from the prior year.
- Amortization of Deferred Charges was $304000.0 for Q2 2026 at Omnicell, down from $497000.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $1.3 million in Q4 2023 and troughed at $294000.0 in Q2 2025.
- A 5-year average of $749388.9 and a median of $772500.0 in 2023 frame the typical range for Amortization of Deferred Charges.
- Across the five-year window, Amortization of Deferred Charges surged 31.39% in 2022 and sank 62.21% in 2025, its largest moves.
- Over 5 years, Amortization of Deferred Charges stood at $1.0 million in 2022, then rose by 20.61% to $1.3 million in 2023, then plunged by 30.76% to $871000.0 in 2024, then plunged by 43.05% to $496000.0 in 2025, then plunged by 38.71% to $304000.0 in 2026.
- The last three Amortization of Deferred Charges figures came in at $304000.0 (Q2 2026), $497000.0 (Q1 2026), and $496000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 304,000.00 |
| Mar 31, 2026 | 497,000.00 |
| Dec 31, 2025 | 496,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 294,000.00 |
| Mar 31, 2025 | 735,000.00 |
| Dec 31, 2024 | 871,000.00 |
| Sep 30, 2024 | 780,000.00 |
| Jun 30, 2024 | 778,000.00 |
| Mar 31, 2024 | 971,000.00 |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 773,000.00 |
| Jun 30, 2023 | 772,000.00 |
| Mar 31, 2023 | 1.05 Mn |
| Dec 31, 2022 | 1.04 Mn |
| Sep 30, 2022 | 768,000.00 |
| Jun 30, 2022 | 766,000.00 |
| Mar 31, 2022 | 1.04 Mn |
| Dec 31, 2021 | 870,000.00 |
| Sep 30, 2021 | 589,000.00 |